Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results

Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA , /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fiscal Fourth Quarter 2025 Summary (compared to prior-year quarter) Platform revenue up 21% to $5.2 million. Annual Recurring Revenue ("ARR") up 20% to $20.9 million, which includes approximately $14.2 million of B2B recurring revenue and $6.7 million of B2C recurring revenue. Total revenue of $12.4 million, a 3% increase. Gross profit up 12%. Total gross margin improved 450 basis points to 51%, crossing 50% on a blended basis for the first time in the Company's history. Net income of $2.4 million, or $0.07 per diluted share, compared to net loss of $2.8 million or ($0.09) per share. This quarter's result includes a $1.1 million favorable adjustment related to the final earnout adjustment for Scite. Last year's result included a negative adjustment charge in other expense of approximately $4.3 million related to the projected earnout for Scite. Adjusted EBITDA increased 15% to a Company record of $1.6 million. Cash flow from operations of $2.3 million, compared to $2.0 million. Fiscal Year 2025 Summary (compared to Fiscal 2024) Platform revenue up 36% to $19.0 million. Total revenue of $49.1 million, a 10% increase. Gross profit up 23%. Total gross margin improved 530 basis points to 49.3%. Net income of $1.3 million, or $0.04 per diluted share, compared to a net loss of $3.8 million, or ($0.13) per share. This year's result includes $1.7 million of net other expense related to the Scite earn-out compared to $5.1 million of net other expense related to the Scite earnout in fiscal 2024. Adjusted EBITDA of $5.3 million, a Company record, compared to $2.2 million. Cash flow from operations of $7.0 million, a Company record, compared to $3.6 million. The Company ended the fiscal year with $12.2 million in cash and cash equivalents. "Fiscal 2025 reflects a year of significant progress in our ongoing SaaS software and AI solution set transition, with our platform revenue now representing nearly 40% of total revenue for the year compared to 31% in fiscal 2024. As expected, this strategic shift and continued focus on recurring revenue has also translated into meaningful increases in gross margin, Adjusted EBITDA and operating cash flow," said Roy W. Olivier, President and CEO of Research Solutions. "Following the final earnout calculation for Scite, we proactively adjusted the payout structure, offering more cash and reducing dilution to current shareholders. We remain focused on improving on our 'Rule of 40' goal, with a slight bias towards increased growth versus profitability, which in turn should create long-term value for our shareholders. In addition, we used the Scite acquisition to help build out the AI capabilities in our product set and we continue to actively pursue additional opportunities that enhance, complement and strengthen our current product offerings. The growth rate of our AI-based Scite product is over 40%, which I view as a good indication that we are on the right track. Lastly, from a cash and Adjusted EBITDA perspective, we are better positioned than we ever have been to execute on these opportunities." Fiscal Fourth Quarter 2025 Results Total revenue was $12.4 million, compared to $12.1 million in the year-ago quarter driven by increased platform revenue versus the prior-year period. Platform subscription revenue for the quarter was $5.2 million, a 21% year-over-year increase from the prior-year period. The increase was due to organic growth in the core B2C and B2B platforms, with the latter increasing due to a mix of new logo generation and upsell and cross sell into existing customers. The quarter ended with annual recurring revenue of $20.9 million, up 20% year-over-year (see the Company's definition of annual recurring revenue below). Transaction revenue was $7.3 million, compared to $7.9 million in the fourth quarter of fiscal 2024. The decrease was due to lower paid order volume. The transaction active customer count for the quarter was 1,338, compared to 1,398 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below). Total gross margin improved 450 basis points from the prior-year quarter to 51.0%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business. Total operating expenses were $5.1 million, compared to $5.0 million in the fourth quarter of 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced stock compensation expense. Other income for the quarter was approximately $1.2 million compared to other expense of approximately $3.5 million in the fourth quarter of fiscal 2024. This quarter's result includes a $1.1 million favorable adjustment related to the final determination of the Scite earnout. Last year's result included a negative adjustment in other expense of approximately $4.3 million related to the projected earnout for Scite. Net income in the fourth quarter was $2.4 million, or $0.07 per diluted share, compared to net loss of $2.8 million, or ($0.09) per share, in the prior-year quarter. Adjusted EBITDA was $1.6 million, compared to $1.4 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below). Full-Year Fiscal 2025 Results Total revenue was $49.1 million, a 10% increase from fiscal 2024, driven by increased platform revenue. Platform subscription revenue for fiscal 2025 was $19.0 million, a 36% year-over-year increase. The increase was primarily due to organic growth in the core B2C and B2B platforms, including 150 net new B2B platform deployments, as well as having a full fiscal year of Scite revenue (versus seven months in fiscal 2024). Transaction revenue was $30.1 million, compared to $30.7 million in fiscal 2024. The decrease was due to lower paid order volume in the second half of fiscal 2025. Total gross margin improved 530 basis points from the prior-year to 49.3%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business. Total operating expenses for the year were $21.7 million, compared to $20.4 million in fiscal 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced general and administrative and stock compensation expenses. Net income for fiscal 2025 was $1.3 million, or $0.04 per diluted share, compared to net loss of $3.8 million, or ($0.13) per share, in the prior year. Adjusted EBITDA was $5.3 million, compared to $2.2 million in fiscal 2024 (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below). Conference CallResearch Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period. Date: Thursday, September 18, 2025Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-518-9783Conference ID: RESEARCH The conference call will be broadcast live and available for replay until October 18, 2025 by dialing 1-412-317-6671 and using the replay ID 11159860, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/. Fiscal Fourth Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter Quarter Ended June 30, Twelve Months Ended June 30, 2025 2024 Change % Change 2025 2024 Change % Change Revenue: Platforms $ 5,184,864 $ 4,277,338 $ 907,526 21.2 % $ 18,955,695 $ 13,956,517 $ 4,999,178 35.8 % Transactions $ 7,253,053 $ 7,856,176 (603,123) -7.7 % $ 30,102,286 $ 30,667,382 (565,096) -1.8 % Total Revenue 12,437,917 12,133,514 304,403 2.5 % 49,057,981 44,623,899 4,434,082 9.9 % Gross Profit: Platforms 4,590,639 3,650,286 940,353 25.8 % 16,584,155 11,889,314 4,694,841 39.5 % Transactions 1,751,263 1,992,580 (241,317) -12.1 % 7,611,796 7,750,852 (139,056) -1.8 % Total Gross Profit 6,341,902 5,642,866 699,036 12.4 % 24,195,951 19,640,166 4,555,785 23.2 % Gross profit as a % of revenue: Platforms 88.5 % 85.3 % 3.2 % 87.5 % 85.2 % 2.3 % Transactions 24.1 % 25.4 % -1.2 % 25.3 % 25.3 % 0.0 % Total Gross Profit 51.0 % 46.5 % 4.5 % 49.3 % 44.0 % 5.3 % Operating Expenses: Sales and marketing 1,219,184 830,195 388,989 46.9 % 5,360,356 3,442,503 1,917,853 55.7 % Technology and product development 1,356,801 1,489,491 (132,690) -8.9 % 5,631,344 5,442,382 188,962 3.5 % General and administrative 2,152,855 1,917,907 234,948 12.3 % 7,936,644 8,511,697 (575,053) -6.8 % Depreciation and amortization 315,021 311,004 4,017 1.3 % 1,245,362 836,271 409,091 48.9 % Stock-based compensation 176,611 426,190 (249,579) -58.6 % 1,723,561 2,155,461 (431,900) -20.0 % Foreign currency translation loss (gain) (83,322) 6,336 (89,658) NM (202,527) 21,395 (223,922) NM Total Operating Expenses 5,137,150 4,981,123 156,027 3.1 % 21,694,740 20,409,709 1,285,031 6.3 % Income (loss) from operations 1,204,752 661,743 543,009 82.1 % 2,501,211 (769,543) 3,270,754 NM Other Income (Expenses): Other income (expenses) 1,163,557 (3,451,948) 4,615,505 NM (1,152,847) (2,903,983) 1,751,136 NM Provision for income taxes (7,995) (31,022) 23,027 -74.2 % (82,811) (113,071) 30,260 -26.8 % Total Other Income (Expenses): 1,155,562 (3,482,970) 4,638,532 NM (1,235,658) (3,017,054) 1,781,396 NM Net income (loss) $ 2,360,314 $ (2,821,227) 5,181,541 NM $ 1,265,553 $ (3,786,597) 5,052,150 NM NM Adjusted EBITDA $ 1,613,062 $ 1,405,273 $ 207,789 14.8 % $ 5,267,607 $ 2,243,584 $ 3,024,023 134.8 % Quarter Ended June 30, Twelve Months Ended June 30, 2025 2024 Change % Change 2025 2024 Change % Change Platforms: B2B ARR (Annual recurring revenue*): Beginning of Period $ 13,474,074 $ 11,653,062 $ 1,821,012 15.6 % $ 12,060,201 $ 9,444,129 $ 2,616,072 27.7 % Incremental ARR 723,524 407,139 316,385 77.7 % 2,137,397 2,616,072 (478,675) -18.3 % End of Period $ 14,197,598 $ 12,060,201 $ 2,137,397 17.7 % $ 14,197,598 $ 12,060,201 $ 2,137,397 17.7 % Deployments: Beginning of Period 1,133 983 150 15.3 % 1,021 835 186 22.3 % Incremental Deployments 38 38 - 0.0 % 150 186 (36) -19.4 % End of Period 1,171 1,021 150 14.7 % 1,171 1,021 150 14.7 % ASP (Average sales price): Beginning of Period $ 11,892 $ 11,855 $ 38 0.3 % $ 11,812 $ 11,310 $ 502 4.4 % End of Period $ 12,124 $ 11,812 $ 312 2.6 % $ 12,124 $ 11,812 $ 312 2.6 % B2C ARR (Annual recurring revenue*): Beginning of Period $ 6,877,926 $ 4,902,975 $ 1,974,951 NM $ 5,363,129 $ - $ 5,363,129 NM Incremental ARR (156,570) 460,154 (616,724) NM 1,358,227 5,363,129 (4,004,902) NM End of Period $ 6,721,356 $ 5,363,129 $ 1,358,227 25.3 % $ 6,721,356 $ 5,363,129 $ 1,358,227 25.3 % Total ARR (Annualized recurring revenue): $ 20,918,954 $ 17,423,330 $ 3,495,624 20.1 % $ 20,918,954 $ 17,423,330 $ 3,495,624 20.1 % Transaction Customers: Corporate customers 1,028 1,093 (65) -5.9 % 1,053 1,088 (35) -3.2 % Academic customers 310 305 5 1.6 % 320 316 4 1.3 % Total customers 1,338 1,398 (60) -4.3 % 1,373 1,404 (31) -2.2 % Active Customer Accounts, Transactions and Annual Recurring Revenue The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month. A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform. The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve. Use of Non-GAAP Measure – Adjusted EBITDA Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results. The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss): Quarter Ended June 30, Twelve Months Ended June 30, 2025 2024 Change % Change 2025 2024 Change % Change Net Income (loss) $ 2,360,314 $ (2,821,227) $ 5,181,541 NM $ 1,265,553 $ (3,786,597) $ 5,052,150 NM Add (deduct): Other (income) expense (1,163,557) 3,451,948 (4,615,505) NM 1,152,847 2,903,983 (1,751,136) NM Foreign currency translation loss (gain) (83,322) 6,336 (89,658) NM (202,527) 21,395 (223,922) NM Provision for income taxes 7,995 31,022 (23,027) -74.2 % 82,811 113,071 (30,260) -26.8 % Depreciation and amortization 315,021 311,004 4,017 1.3 % 1,245,362 836,271 409,091 48.9 % Stock-based compensation 176,611 426,190 (249,579) -58.6 % 1,723,561 2,155,461 (431,900) -20.0 % Adjusted EBITDA $ 1,613,062 $ 1,405,273 $ 207,789 14.8 % $ 5,267,607 $ 2,243,584 $ 3,024,023 134.8 % About Research SolutionsResearch Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com. Important Cautions Regarding Forward-Looking Statements Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. Research Solutions, Inc. and Subsidiaries Consolidated Balance Sheets (Unaudited) June 30, June 30, 2025 2024 Assets Current assets: Cash and cash equivalents $ 12,227,312 $ 6,100,031 Accounts receivable, net of allowance of $182,324 and $68,579, respectively 7,191,234 6,879,800 Prepaid expenses and other current assets 580,257 643,553 Prepaid royalties 925 1,067,237 Total current assets 19,999,728 14,690,621 Non-current assets: Property and equipment, net of accumulated depreciation of $964,883 and $922,558, respectively 60,769 88,011 Intangible assets, net of accumulated amortization of $2,736,773 and $1,535,310, respectively 9,686,241 10,764,261 Goodwill 16,372,979 16,315,888 Deposits and other assets 957 981 Total assets $ 46,120,674 $ 41,859,762 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses $ 7,443,757 $ 8,843,612 Deferred revenue 10,702,120 9,023,848 Contingent earnout liability, current portion 7,363,152 — Total current liabilities 25,509,029 17,867,460 Non-current liabilities: Contingent earnout liability, long-term portion 6,683,488 12,298,114 Total liabilities 32,192,517 30,165,574 Commitments and contingencies Stockholders' equity: Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding — — Common stock; $0.001 par value; 100,000,000 shares authorized; 32,479,993 and 32,295,373 sharesissued and outstanding, respectively 32,480 32,295 Additional paid-in capital 39,059,557 38,089,958 Accumulated deficit (25,043,693) (26,309,246) Accumulated other comprehensive loss (120,187) (118,819) Total stockholders' equity 13,928,157 11,694,188 Total liabilities and stockholders' equity $ 46,120,674 $ 41,859,762 Research Solutions, Inc. and Subsidiaries Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) Years Ended June 30, 2025 2024 Revenue: Platforms $ 18,955,695 $ 13,956,517 Transactions 30,102,286 30,667,382 Total revenue 49,057,981 44,623,899 Cost of revenue: Platforms 2,371,540 2,067,203 Transactions 22,490,490 22,916,530 Total cost of revenue 24,862,030 24,983,733 Gross profit 24,195,951 19,640,166 Operating expenses: Selling, general and administrative 20,449,378 19,573,438 Depreciation and amortization 1,245,362 836,271 Total operating expenses 21,694,740 20,409,709 Income (loss) from operations 2,501,211 (769,543) Other income 595,679 333,088 Change in fair value of contingent earnout liability (1,748,526) (3,237,071) Income (loss) before provision for income taxes 1,348,364 (3,673,526) Provision for income taxes (82,811) (113,071) Net income (loss) 1,265,553 (3,786,597) Other comprehensive income (loss): Foreign currency translation (1,368) (595) Comprehensive income (loss) $ 1,264,185 $ (3,787,192) Basic income (loss) per common share: Net income (loss) per share $ 0.04 $ (0.13) Weighted average common shares outstanding 30,681,187 28,863,949 Diluted income (loss) per common share: Net income (loss) per share $ 0.04 $ (0.13) Weighted average common shares outstanding 31,503,972 28,863,949 Research Solutions, Inc. and Subsidiaries Consolidated Statements of Cash Flows (Unaudited) Years Ended June 30, 2025 2024 Cash flow from operating activities: Net income (loss) $ 1,265,553 $ (3,786,597) Adjustment to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 1,245,362 836,271 Stock options expense 205,457 140,150 Restricted common stock expense 1,518,104 1,994,362 Modification cost of accelerated vesting of restricted common stock — 20,949 Adjustment to contingent earnout liability 1,748,526 3,237,071 Changes in operating assets and liabilities: Accounts receivable (341,434) (344,020) Prepaid expenses and other current assets 63,296 (164,579) Prepaid royalties 1,066,312 135,441 Accounts payable and accrued expenses (1,426,282) 560,027 Deferred revenue 1,678,272 921,879 Net cash provided by operating activities 7,023,166 3,550,954 Cash flow from investing activities: Purchase of property and equipment (19,261) (71,510) Payment for acquisition of Resolute, net of cash acquired — (2,718,253) Payment for acquisition of Scite, net of cash acquired — (7,305,493) Net cash used in investing activities (19,261) (10,095,256) Cash flow from financing activities: Proceeds from the exercise of stock options 180,800 — Common stock repurchase (934,577) (554,202) Payment of contingent acquisition consideration (124,107) (351,649) Net cash used in financing activities (877,884) (905,851) Effect of exchange rate changes 1,260 4,851 Net increase (decrease) in cash and cash equivalents 6,127,281 (7,445,302) Cash and cash equivalents, beginning of period 6,100,031 13,545,333 Cash and cash equivalents, end of period $ 12,227,312 $ 6,100,031 Supplemental disclosures of cash flow information: Cash paid for income taxes $ 82,811 $ 113,071 Non-cash investing and financing activities: Contingent consideration accrual on asset acquisition $ 31,359 $ 32,022 SOURCE Research Solutions, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results

FAQ

Why Very Bullish?

How important is it?

Why Long Term?

Related Companies

Related News